Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells

被引:192
作者
Behrens, I
Stenberg, P
Artursson, P
Kissel, T
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Uppsala Univ, Div Pharmaceut & Biopharm, SE-75123 Uppsala, Sweden
关键词
mucus layer; HT29-MTX; drug absorption; barbiturates; Caco-2; cell culture;
D O I
10.1023/A:1010974909998
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. A new mucus-secreting in vitro drug absorption model based on monolayers of goblet-cell like sub-clones of the human colon carcinoma cell line HT29 obtained by methotrexate (MTX) treatment was investigated. Methods. Twelve sub-clones were isolated and characterized by light microscopy (LM), transelectron microscopy (TEM), confocal laser scanning microscopy (CLSM), transepithelial electrical resistance (TEER) and the transport of a paracellular marker FITC-Dextran (Mw 4400) (FD-4). Results. Significant differences of microscopical appearance, TEER-values and permeability of FD-4 between the sub-clones were evident. However, two of them, namely MTX-DI and MTX-E12, formed tight confluent monolayers with a thick mucus-layer on the apical surface. They were used to compare the apparent permeability coefficient (P-app) of a series of lipophilic drugs, which should be affected by the mucus-layer, namely barbiturates (barbituric acid, barbital, phenobarbital, methylphenobarbital and heptabarbital) and testosterone, as a reference, to mucus-free Caco-2 cells. The permeability of drugs with a partition coefficient (log P) > I was decreased in the mucus-producing cell lines. Testosterone, the most lipophilic compound, showed a decrease of up to 43%. Conclusions. We demonstrated that the mucus layer is a significant barrier to drug absorption for lipophilic drugs. In conclusion, our model may serve as a suitable in-vitro cell culture model to study the influence of the mucus layer on drug diffusion.
引用
收藏
页码:1138 / 1145
页数:8
相关论文
共 31 条
  • [1] PASSIVE DIFFUSION OF WEAK ORGANIC ELECTROLYTES ACROSS CACO-2 CELL MONOLAYERS - UNCOUPLING THE CONTRIBUTIONS OF HYDRODYNAMIC, TRANSCELLULAR, AND PARACELLULAR BARRIERS
    ADSON, A
    BURTON, PS
    RAUB, TJ
    BARSUHN, CL
    AUDUS, KL
    HO, NFH
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (10) : 1197 - 1204
  • [2] SODIUM CAPRATE ELICITS DILATATIONS IN HUMAN INTESTINAL TIGHT JUNCTIONS AND ENHANCES DRUG ABSORPTION BY THE PARACELLULAR ROUTE
    ANDERBERG, EK
    LINDMARK, T
    ARTURSSON, P
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (06) : 857 - 864
  • [3] Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond
    Artursson, P
    Borchardt, RT
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (12) : 1655 - 1658
  • [4] RIBOPROBE EXPRESSION CASSETTES FOR MEASURING IGF-I, BETA-ACTIN AND GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE TRANSCRIPTS
    BIRAGYN, A
    ARKINS, S
    KELLEY, KW
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 168 (02) : 235 - 244
  • [5] Mucin gene expression in human embryonic and fetal intestine
    Buisine, MP
    Devisme, L
    Savidge, TC
    Gespach, C
    Gosselin, B
    Porchet, N
    Aubert, JP
    [J]. GUT, 1998, 43 (04) : 519 - 524
  • [6] Oligosaccharides expressed an MUC1 produced by pancreatic and colon tumor cell lines
    Burdick, MD
    Harris, A
    Reid, CJ
    Iwamura, T
    Hollingsworth, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) : 24198 - 24202
  • [7] HOUNSELL EF, 1982, MED BIOL, V60, P227
  • [8] ABSORPTIVE AND MUCUS-SECRETING SUBCLONES ISOLATED FROM A MULTIPOTENT INTESTINAL-CELL LINE (HT-29) PROVIDE NEW MODELS FOR CELL POLARITY AND TERMINAL DIFFERENTIATION
    HUET, C
    SAHUQUILLOMERINO, C
    COUDRIER, E
    LOUVARD, D
    [J]. JOURNAL OF CELL BIOLOGY, 1987, 105 (01) : 345 - 357
  • [9] JACKSON MJ, 1987, PHYSL GASTROINTESTIN, P1597
  • [10] Evaluation of absorption enhancement for a potent cyclopeptidic ανβ3-antagonist in a human intestinal cell line (Caco-2)
    Kamm, W
    Jonczyk, A
    Jung, T
    Luckenbach, G
    Raddatz, P
    Kissel, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (03) : 205 - 214